Zeiss has now released a video for marketing purposes which features CONVIVO as an integral component of their tumour workflow model. This involves a staged process from diagnosis through to treatment of cancers in the Central Nervous System. Zeiss has all the tools from KINEVO 900 through CONVIVO to radiotherapy. There were 296,851 tumours in the CNS identified in 2018.
https://www.zeiss.com/meditec/int/c/tumor-workflow-video.html
Zeiss are clearly serious in this field and are leading the world. OIL shareholders will be rewarded at some stage but timing is still hard to predict.
- Forums
- ASX - By Stock
- OIL
- Zeiss marketing of Convivo
OIL
optiscan imaging limited
Add to My Watchlist
0.00%
!
8.5¢

Zeiss marketing of Convivo
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
8.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $71.00M |
Open | High | Low | Value | Volume |
8.5¢ | 8.5¢ | 8.5¢ | $476 | 5.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 6764 | 8.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.5¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 6764 | 0.085 |
1 | 60000 | 0.084 |
1 | 8000 | 0.083 |
2 | 42550 | 0.081 |
4 | 117512 | 0.080 |
Price($) | Vol. | No. |
---|---|---|
0.095 | 50000 | 1 |
0.100 | 103621 | 2 |
0.105 | 242487 | 3 |
0.110 | 200712 | 4 |
0.120 | 55683 | 4 |
Last trade - 15.02pm 15/09/2025 (20 minute delay) ? |
Featured News
OIL (ASX) Chart |
The Watchlist
FBM
FUTURE BATTERY MINERALS LIMITED
Nick Rathjen, MD & CEO
Nick Rathjen
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online